Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > This was the email

<< Previous

Bullboard Posts

Next >>

Comment by gebremeskelon Aug 01, 2024 1:11pm

116 Views

Post# 36158596

RE:RE:This was the email

No. It was not released too early and it was not a mistake. They released the last financials early as well.

riverrrow wrote: Was this email released a few weeks too early by mistake? They usually don't release financials until the last day or two before the end of the month. That would explain the last of the sunshine re. summer remark.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program